This is where Anne Schwartz is doing an internship this week. They state that their mission is "to be the leader in the application of monoclonal antibodies for the treatment of cancer. We aim to achieve this by exploiting our expertise and experience in the identification of potential biological targets for cancer treatments, the development and humanization of monoclonal antibodies, and the creation of potent cell-killing agents designed for delivery by antibodies. Our Targeted Antibody Payload (TAP) technology uses tumor-targeting antibodies to deliver a highly potent cell-killing agent specifically to cancer cells to kill these cells with minimal damage to healthy tissue."
Posted on: Fri, 12 Jul 2013 18:13:21 +0000
Trending Topics
Recently Viewed Topics
© 2015